Andy Theodorou is a seasoned professional at The RSA Group, where he serves as a Senior Consultant specializing in executive search within the pharmaceuticals and life sciences sectors. With a robust academic foundation in Pharmaceutical Sciences and over 15 years of experience in executive search,...
Andy Theodorou is a seasoned professional at The RSA Group, where he serves as a Senior Consultant specializing in executive search within the pharmaceuticals and life sciences sectors. With a robust academic foundation in Pharmaceutical Sciences and over 15 years of experience in executive search, Andy has developed a keen understanding of the complexities and nuances of talent acquisition in this dynamic industry. His expertise spans a wide array of functions, including Discovery Research, Clinical Development, and Commercial Management, allowing him to provide comprehensive advisory services to his clients.
At RSA, Andy is particularly focused on roles within Research & Development, Medical Affairs, Market Access, and Commercial Strategy. His deep knowledge of the pharmaceutical landscape, combined with his proficiency in regulatory affairs and talent management, positions him as a trusted advisor for organizations seeking to appoint senior-level professionals who can drive innovation and growth. Andy's extensive network and insights into the biotechnology sector enable him to identify and attract top-tier talent, particularly in specialized areas like oncology and respiratory therapy.
Key projects that Andy has spearheaded include high-stakes searches for executives in leading pharmaceutical companies, where he has successfully matched candidates with the strategic vision and cultural fit necessary for success. His ability to navigate the intricacies of the industry, coupled with his passion for fostering meaningful connections, makes him an invaluable asset to both clients and candidates alike. As he continues to leverage his unique blend of scientific knowledge and executive search expertise, Andy remains committed to advancing the capabilities of organizations within the life sciences arena.
